PRME Q4 2025 Earnings — Prime Medicine, Inc. Revenue & Financial Results | Market Cap Arena

PRMEPrime Medicine, Inc.

$771M

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$838,000-61.6% YoY

Gross Profit

$42M5019.1% margin

Operating Income

-$49M-5800.5% margin

Net Income

-$46M-5498.7% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

-31.6%

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$38M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$343M

Total Liabilities

$222M

Stockholders' Equity

$121M

Cash & Equivalents

$63M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$838,000	$2M	-61.6%
Gross Profit	$42M	$2M	+1826.7%
Operating Income	-$49M	-$44M	-9.9%
Net Income	-$46M	-$42M	-9.0%

Revenue Segments

Reportable Segment

$838,000100%